Cleared Traditional

K951595 - ROCHE COBAS INTEGRA ANALYZER

K951595 is the FDA 510(k) clearance for ROCHE COBAS INTEGRA ANALYZER by Roche Diagnostic Systems, Inc.. It is a Class 2 Chemistry device (product code CGX) cleared through the Traditional 510(k) pathway after a 155-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1995
Decision
155d
Days
Class 2
Risk

K951595 is an FDA 510(k) clearance for the ROCHE COBAS INTEGRA ANALYZER, REAGENT CASSETTES. Classified as Alkaline Picrate, Colorimetry, Creatinine (product code CGX), Class II - Special Controls.

Submitted by Roche Diagnostic Systems, Inc. (Somerville, US). The FDA issued a Cleared decision on September 8, 1995 after a review of 155 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1225 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Roche Diagnostic Systems, Inc. devices

Submission Details

510(k) Number K951595 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 1995
Decision Date September 08, 1995
Days to Decision 155 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
67d slower than avg
Panel avg: 88d · This submission: 155d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGX Alkaline Picrate, Colorimetry, Creatinine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGX Alkaline Picrate, Colorimetry, Creatinine

All 100
Devices cleared under the same product code (CGX) and FDA review panel - the closest regulatory comparables to K951595.
RANDOX CREATININE
K973993 · Randox Laboratories, Ltd. · Mar 1998
SIGMA DIAGNOSTICS CREATININE REAGENT, SIGMA DIAGNOSTICS CREATININE REAGENT
K972743 · Sigma Diagnostics, Inc. · Sep 1997
SIGMA DIAGNOSTICS CREATININE REAGENT KIT
K963534 · Sigma Diagnostics, Inc. · Sep 1996
CREATININE-PO REAGENT KIT
K943924 · Synermed, Inc. · Sep 1994
ROCHE REAGENT FOR CREATININE
K941837 · Roche Diagnostic Systems, Inc. · Aug 1994
KODAK EKTACHEM DT SLIDES (URCR)
K934071 · Eastman Kodak Company · Mar 1994